Workshop on the TFOS (DEWSII) Report
01 September 2021
09:30 PM, UAE time
Chairman
Dr. Murad Alobthani, UAE
Moderator
Prof. Saleh Messabi, President of ESO, UAE
Speakers
Prof. Jennifer P. Craig, New Zealand
Prof. José Gomes, Brazil
Prof. James Wolffsohn, United Kingdom
Prof. Lyndon Jones, Canada
Our purpose is to reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.
At Novartis, we invest in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs.
We use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Our researchers combine imagination with the rigor of collaborative science to find better treatments for disease.
